Insights

Greg Merril

Chief Executive Officer at Adaptive Phage Therapeutics

Mr. Greg Merril is a serial life-science entrepreneur, recognized by Ernst & Young as a regional Entrepreneur of the Year winner. He has served as Chair of several international phage therapy conferences. As prior founding CEO of Immersion Medical (NASDQ: IMMR) he led the creation of the world’s first commercially successful virtual reality surgical training simulators resulting in a company that was one of Maryland’s fastest revenue growth technology firms for four consecutive years. IMMR had peak market capitalization of over $1 billion. Greg has been recognized as a TEDMED Innovation Scholar for his work developing and commercializing head impact sensor technology to address the issue of sports-related traumatic brain injury. During his career Greg’s product developed efforts have been recognized twice as Innovation of the Year by the Consumer Electronic Association (CEA)/ Industrial Designers Society of America (IDSA). Other awards have included the 2015 International Sports Technology Award for Best Wearable Technology, and his previous company was selected as a Wall Street Journal Startup Company of the Year.

Roles

  • Chief Executive Officer

    Current role

Social

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.